These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 10807491)

  • 1. Evidence of the dual mechanisms of action of venlafaxine.
    Harvey AT; Rudolph RL; Preskorn SH
    Arch Gen Psychiatry; 2000 May; 57(5):503-9. PubMed ID: 10807491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers.
    Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
    Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P
    Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of serotonin and noradrenaline reuptake inhibitors on human platelet adhesion and coagulation.
    Hallbäck I; Hägg S; Eriksson AC; Whiss PA
    Pharmacol Rep; 2012; 64(4):979-83. PubMed ID: 23087151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
    Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
    Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: II. In vitro studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1813-22. PubMed ID: 10884562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats.
    Koch S; Hemrick-Luecke SK; Thompson LK; Evans DC; Threlkeld PG; Nelson DL; Perry KW; Bymaster FP
    Neuropharmacology; 2003 Dec; 45(7):935-44. PubMed ID: 14573386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of sustained administration of the serotonin and norepinephrine reuptake inhibitor venlafaxine: I. in vivo electrophysiological studies in the rat.
    Béïque J; de Montigny C; Blier P; Debonnel G
    Neuropharmacology; 2000 Jul; 39(10):1800-12. PubMed ID: 10884561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
    Cooke JD; Cavender HM; Lima HK; Grover LM
    Psychopharmacology (Berl); 2014 Dec; 231(23):4429-41. PubMed ID: 24781518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    Ball SE; Ahern D; Scatina J; Kao J
    Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET neuroimaging with [11C]venlafaxine: serotonin uptake inhibition, biodistribution and binding in living pig brain.
    Smith DF; Jensen PN; Gee AD; Hansen SB; Danielsen E; Andersen F; Saiz PA; Gjedde A
    Eur Neuropsychopharmacol; 1997 Aug; 7(3):195-200. PubMed ID: 9213078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine.
    Rahman Z; Ring RH; Young K; Platt B; Lin Q; Schechter LE; Rosenzweig-Lipson S; Beyer CE
    Brain Res; 2008 Apr; 1203():68-78. PubMed ID: 18321472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
    David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
    Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychopharmacological profile of venlafaxine].
    Bourin M
    Encephale; 1999 Jun; 25 Spec No 2():21-2; discussion 23-5. PubMed ID: 10434156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of serotonin selective, norepinephrine selective, and dual serotonin and norepinephrine reuptake inhibitors on lower urinary tract function in cats.
    Katofiasc MA; Nissen J; Audia JE; Thor KB
    Life Sci; 2002 Aug; 71(11):1227-36. PubMed ID: 12106588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.